Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

ClinicalTrials.gov ID: NCT05128344

Public ClinicalTrials.gov record NCT05128344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of AMZ002, Compared to Vigabatrin, in the Treatment of Infantile Spasms

Study identification

NCT ID
NCT05128344
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amzell
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • AMZ002 injectable solution, 0.5mg/mL Drug
  • Vigabatrin, oral Drug

Drug

Eligibility (public fields only)

Age range
2 Months to 24 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2023
Primary completion
May 31, 2025
Completion
Nov 30, 2025
Last update posted
Apr 19, 2023

2023 – 2025

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
The Childrens Hospital Colorado Aurora Colorado 80045-7106
Miami Children's Hospital Miami Florida 33155
Advent Health Orlando Orlando Florida 32803
Arnold Palmer Hospital For Children Orlando Florida 32806
Childrens Healthcare of Atlanta Atlanta Georgia 30329
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Kentucky Hospital Lexington Kentucky 40536
Children's Brain Institute Lexington Massachusetts 02420
Children's Hospital of Michigan Detroit Michigan 48201-2119
Staten Island University Hospital, North Staten Island New York 10305
Wake Forest Baptist Medical Center - PPDS Winston-Salem North Carolina 27157
UT Southwestern Medical Center Dallas Texas 75207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05128344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05128344 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →